CA1029303A - Method of contraception by the administration of stage-combination preparations - Google Patents

Method of contraception by the administration of stage-combination preparations

Info

Publication number
CA1029303A
CA1029303A CA216,593A CA216593A CA1029303A CA 1029303 A CA1029303 A CA 1029303A CA 216593 A CA216593 A CA 216593A CA 1029303 A CA1029303 A CA 1029303A
Authority
CA
Canada
Prior art keywords
contraception
administration
stage
combination preparations
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA216,593A
Other languages
English (en)
French (fr)
Inventor
Alan G. Pitchford
Ursula Lachnit-Fixson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of CA1029303A publication Critical patent/CA1029303A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CA216,593A 1973-12-21 1974-12-20 Method of contraception by the administration of stage-combination preparations Expired CA1029303A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2365103A DE2365103C3 (de) 1973-12-21 1973-12-21 V erwendung von Hormonen zur Kontrazeption

Publications (1)

Publication Number Publication Date
CA1029303A true CA1029303A (en) 1978-04-11

Family

ID=5902211

Family Applications (1)

Application Number Title Priority Date Filing Date
CA216,593A Expired CA1029303A (en) 1973-12-21 1974-12-20 Method of contraception by the administration of stage-combination preparations

Country Status (13)

Country Link
US (1) US3957982A (nl)
BE (1) BE823689A (nl)
CA (1) CA1029303A (nl)
CY (1) CY1065A (nl)
DE (1) DE2365103C3 (nl)
DK (1) DK155308C (nl)
GB (1) GB1490099A (nl)
HK (1) HK47080A (nl)
KE (1) KE3059A (nl)
MY (1) MY8100118A (nl)
NL (1) NL178845C (nl)
SE (1) SE441233B (nl)
ZA (1) ZA748128B (nl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US4425339A (en) 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4610687A (en) * 1984-08-06 1986-09-09 Board Of Trustees Operating Michigan State University Method for breeding control in female bovines
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US4958736A (en) * 1986-03-18 1990-09-25 Gynex, Inc. Package for oral contraceptive tablet
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
DK174724B1 (da) † 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
CA1336328C (en) * 1988-04-11 1995-07-18 Walter G. Leonard Method of increasing bone density in humans
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
JP2000515888A (ja) * 1996-07-26 2000-11-28 アメリカン・ホーム・プロダクツ・コーポレイション 経口避妊薬
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US20050038006A1 (en) * 1998-12-23 2005-02-17 Shangold Gary A. Triphasic oral contraceptive
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (nl) * 1966-11-02 1968-05-03
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) * 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
DE2335265A1 (de) * 1973-07-09 1975-01-30 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten

Also Published As

Publication number Publication date
NL178845C (nl) 1986-06-02
DK667674A (nl) 1975-09-08
SE441233B (sv) 1985-09-23
US3957982A (en) 1976-05-18
MY8100118A (en) 1981-12-31
ZA748128B (en) 1976-01-28
GB1490099A (en) 1977-10-26
SE7416039L (nl) 1975-06-23
DK155308B (da) 1989-03-28
BE823689A (fr) 1975-06-20
DE2365103C3 (de) 1980-08-28
DE2365103A1 (de) 1975-07-10
AU7670874A (en) 1976-06-24
KE3059A (en) 1980-07-11
DK155308C (da) 1989-08-28
HK47080A (en) 1980-09-05
CY1065A (en) 1980-10-24
NL178845B (nl) 1986-01-02
NL7416807A (nl) 1975-06-24
DE2365103B2 (de) 1979-12-20

Similar Documents

Publication Publication Date Title
CA1029303A (en) Method of contraception by the administration of stage-combination preparations
CA1027946A (en) Process for the preparation of 5-fluorouracil derivatives
CA1035792A (en) Preparation of 5-sec-alkyl-m-cresol
CA1027447A (en) Device for the administration of powders
CA1029302A (en) Method of contraception by the administration of stage-combination preparations
CA1014974A (en) Process for the preparation of 5-chloro-2-toluidine
CA1036169A (en) Process for the preparation of poly-n-alkyliminoalanes
CA1029018A (en) Process for the preparation of benzothiadiazines
CA1030069A (en) Pharmaceutical preparations
CA1013674A (en) Method of contraception by the administration of stage-combination preparations
CA1001637A (en) Preparation of 3,4,5,6,7,8-hexahydrocoumarin
CA1019347A (en) Process for the preparation of propargylamine
CA1033741A (en) Derivatives of 4-hydroxy-5-azacoumarin
AU483202B2 (en) Method of contraception bythe administration of stage-combination preparations
CA1020945A (en) 2-benzimidazolethiol preparation
CA1013737A (fr) Procede de preparation de l'amplicilline
AU493201B2 (en) Method of contraception bythe administration of stage combination preparations
CA914148A (en) Preparation of 9, 11-dichloro steroids
AU486481B2 (en) Preparation of methylcobalamine
AU479744B2 (en) Method of contraception by the aministration of stage-combustion preparations
AU484885B2 (en) Preparation of latices
AU482093B2 (en) Derivatives of 7&-methylester-4-en-3&, 17b-diol
AU489987B2 (en) New pharmaceutical preparations
AU487964B2 (en) Process for the preparation of 7-amino- 3 - cephem derivatives
CA1023740A (en) Alkanols of octahydrothieno (3,4-b) pyrazine -6,6-dioxides